Monthly Archives - April 2018

05Apr

Siamab Therapeutics to Present New Data on its ST1 Antibody Therapeutic Program Targeting Tumor-Associated STn and STn+ Myeloid Derived Suppressor Cells at the AACR Annual Meeting 2018

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel glycan-targeted cancer therapeutics, today announced that it will present new research findings for its ST1 monoclonal antibody (mAb) therapeutic program during a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2018, being held April 14-18, 2018, at McCormick Place in Chicago. Read more >>
Portfolio News
Read more...
02Apr

Some Thoughts on Pitching

Boston Harbor Angel members, Ziad Moukheiber and David Powsner, are the hosts of Failure – the Podcast, a podcast about about business failures, focusing on startups and emerging companies. The marketing pros will tell you that there's a right way to pitch and many wrong ways.  That may be.  But when you are on the front line, things change.  Mark, Ziad and Dave, in a not-too-serious discussion of pitching investors. Tune in >>  
Blog, Member News, ,
Read more...